Stay updated on Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with basic site chrome, replacing the previous study details; the detailed study content and documents have been removed, leaving an error page.
    Difference
    22%
    Check dated 2026-09-22T00:23:42.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6. This appears to be a minor, metadata-only update to the page rather than a change to the study content.
    Difference
    0.0%
    Check dated 2026-08-31T18:46:22.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, signaling a small patch to the page without altering study information.
    Difference
    0.0%
    Check dated 2026-08-10T10:50:08.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The study document revision was updated from v3.6.3 to v3.6.4, indicating a newer version of the document within the study materials.
    Difference
    0.0%
    Check dated 2026-07-27T05:29:40.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    Revision tag on the page updated from v3.6.2 to v3.6.3, signaling a minor update to the page’s documentation.
    Difference
    0.0%
    Check dated 2026-07-05T12:30:36.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Version tag updated from v3.6.0 to v3.6.2, indicating a small update to the study record's page metadata. This change does not modify the study details or user-visible content.
    Difference
    0.0%
    Check dated 2026-06-28T08:18:06.000Z thumbnail image

Stay in the know with updates to Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page.